BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 37028557)

  • 1. The Relationship of Omega-3 Fatty Acids with Dementia and Cognitive Decline: Evidence from Prospective Cohort Studies of Supplementation, Dietary Intake, and Blood Markers.
    Wei BZ; Li L; Dong CW; Tan CC; ; Xu W
    Am J Clin Nutr; 2023 Jun; 117(6):1096-1109. PubMed ID: 37028557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fish intake, n-3 fatty acid body status, and risk of cognitive decline: a systematic review and a dose-response meta-analysis of observational and experimental studies.
    Kosti RI; Kasdagli MI; Kyrozis A; Orsini N; Lagiou P; Taiganidou F; Naska A
    Nutr Rev; 2022 May; 80(6):1445-1458. PubMed ID: 34605891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intakes of fish and polyunsaturated fatty acids and mild-to-severe cognitive impairment risks: a dose-response meta-analysis of 21 cohort studies.
    Zhang Y; Chen J; Qiu J; Li Y; Wang J; Jiao J
    Am J Clin Nutr; 2016 Feb; 103(2):330-40. PubMed ID: 26718417
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary fatty acids and risk for Alzheimer's disease, dementia, and mild cognitive impairment: A prospective cohort meta-analysis.
    Zhu RZ; Chen MQ; Zhang ZW; Wu TY; Zhao WH
    Nutrition; 2021 Oct; 90():111355. PubMed ID: 34218119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No Effect of Omega-3 Fatty Acid Supplementation on Cognition and Mood in Individuals with Cognitive Impairment and Probable Alzheimer's Disease: A Randomised Controlled Trial.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Int J Mol Sci; 2015 Oct; 16(10):24600-13. PubMed ID: 26501267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary intake of fish and omega-3 fatty acids in relation to long-term dementia risk.
    Devore EE; Grodstein F; van Rooij FJ; Hofman A; Rosner B; Stampfer MJ; Witteman JC; Breteler MM
    Am J Clin Nutr; 2009 Jul; 90(1):170-6. PubMed ID: 19474131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eicosapentaenoic Acid Is Associated with Decreased Incidence of Alzheimer's Dementia in the Oldest Old.
    Melo van Lent D; Egert S; Wolfsgruber S; Kleineidam L; Weinhold L; Wagner-Thelen H; Maier W; Jessen F; Ramirez A; Schmid M; Scherer M; Riedel-Heller SG; Wagner M
    Nutrients; 2021 Jan; 13(2):. PubMed ID: 33573174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of erythrocyte omega-3 fatty acids with cognition, brain imaging and biomarkers in the Alzheimer's disease neuroimaging initiative: cross-sectional and longitudinal retrospective analyses.
    Rouch L; Virecoulon Giudici K; Cantet C; Guyonnet S; Delrieu J; Legrand P; Catheline D; Andrieu S; Weiner M; de Souto Barreto P; Vellas B;
    Am J Clin Nutr; 2022 Dec; 116(6):1492-1506. PubMed ID: 36253968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omega-3 fatty acids and blood-based biomarkers in Alzheimer's disease and mild cognitive impairment: A randomized placebo-controlled trial.
    Lin PY; Cheng C; Satyanarayanan SK; Chiu LT; Chien YC; Chuu CP; Lan TH; Su KP
    Brain Behav Immun; 2022 Jan; 99():289-298. PubMed ID: 34755655
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
    Abdelhamid AS; Brown TJ; Brainard JS; Biswas P; Thorpe GC; Moore HJ; Deane KH; Summerbell CD; Worthington HV; Song F; Hooper L
    Cochrane Database Syst Rev; 2020 Feb; 3(3):CD003177. PubMed ID: 32114706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower omega-3 fatty acid intake and status are associated with poorer cognitive function in older age: A comparison of individuals with and without cognitive impairment and Alzheimer's disease.
    Phillips MA; Childs CE; Calder PC; Rogers PJ
    Nutr Neurosci; 2012 Nov; 15(6):271-7. PubMed ID: 22824373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythrocyte omega-3 fatty acids are inversely associated with incident dementia: Secondary analyses of longitudinal data from the Women's Health Initiative Memory Study (WHIMS).
    Ammann EM; Pottala JV; Robinson JG; Espeland MA; Harris WS
    Prostaglandins Leukot Essent Fatty Acids; 2017 Jun; 121():68-75. PubMed ID: 28651700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omega-3 fatty acids and risk of dementia: the Canadian Study of Health and Aging.
    Kröger E; Verreault R; Carmichael PH; Lindsay J; Julien P; Dewailly E; Ayotte P; Laurin D
    Am J Clin Nutr; 2009 Jul; 90(1):184-92. PubMed ID: 19474137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omega-3 fatty acids and cognitive function.
    Welty FK
    Curr Opin Lipidol; 2023 Feb; 34(1):12-21. PubMed ID: 36637075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ω-3 fatty acids in the prevention of cognitive decline in humans.
    Cederholm T; Salem N; Palmblad J
    Adv Nutr; 2013 Nov; 4(6):672-6. PubMed ID: 24228198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.
    Newberry SJ; Chung M; Booth M; Maglione MA; Tang AM; O'Hanlon CE; Wang DD; Okunogbe A; Huang C; Motala A; Trimmer M; Dudley W; Shanman R; Coker TR; Shekelle PG
    Evid Rep Technol Assess (Full Rep); 2016 Oct; (224):1-826. PubMed ID: 30307735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defining the Optimal Target Population for Trials of Polyunsaturated Fatty Acid Supplementation Using the Erythrocyte Omega-3 Index: A Step Towards Personalized Prevention of Cognitive Decline?
    Coley N; Raman R; Donohue MC; Aisen PS; Vellas B; Andrieu S
    J Nutr Health Aging; 2018; 22(8):982-998. PubMed ID: 30272103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fish and Omega-3 Fatty Acids: Sex and Racial Differences in Cardiovascular Outcomes and Cognitive Function.
    Welty FK; Daher R; Garelnabi M
    Arterioscler Thromb Vasc Biol; 2024 Jan; 44(1):89-107. PubMed ID: 37916414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega-3 fatty acids and risk of cognitive impairment and dementia.
    Laurin D; Verreault R; Lindsay J; Dewailly E; Holub BJ
    J Alzheimers Dis; 2003 Aug; 5(4):315-22. PubMed ID: 14624027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of APOE Genotype on Plasma Docosahexaenoic Acid (DHA), Eicosapentaenoic Acid, Arachidonic Acid, and Hippocampal Volume in the Alzheimer's Disease Cooperative Study-Sponsored DHA Clinical Trial.
    Tomaszewski N; He X; Solomon V; Lee M; Mack WJ; Quinn JF; Braskie MN; Yassine HN
    J Alzheimers Dis; 2020; 74(3):975-990. PubMed ID: 32116250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.